Data gathered: November 15
AI Stock Analysis - Coeptis Therapeutics (COEP)
Analysis generated April 30, 2024. Powered by Chat GPT.
Coeptis Therapeutics is a biopharmaceutical company engaged in the development and commercialization of innovative medical treatments. As a relatively small player in the pharmaceutical industry, Coeptis Therapeutics focuses on addressing unmet medical needs potentially offering a range of products primarily within niche markets. Investment in such companies often involves significant risk and potential for substantial reward, contingent upon the successful development and regulatory approval of their products.
Stock Alerts - Coeptis Therapeutics (COEP)
 |
Coeptis Therapeutics | November 15 Price is down by -5% in the last 24h. |
|
Coeptis Therapeutics | November 14 Price is up by 7% in the last 24h. |
|
Coeptis Therapeutics | November 13 Price is down by -5.1% in the last 24h. |
|
Coeptis Therapeutics | November 8 Price is down by -5.3% in the last 24h. |
Alternative Data for Coeptis Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,291 | Sign up | Sign up | Sign up |
| Twitter Followers | 671 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 7 | Sign up | Sign up | Sign up |
About Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer.
| Price | $0.20 |
| Target Price | Sign up |
| Volume | 558 |
| Market Cap | $8.1M |
| Year Range | $0.16 - $0.48 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical DevelopmentNovember 6 - Yahoo |
Warning: COEP is at high risk of performing badlyNovember 2 - Seeking Alpha |
|
|
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency UseOctober 23 - Yahoo |
Coeptis Therapeutics expands license agreement with DeverraOctober 23 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 0 | 0 | -1.8M | -1.7M | |
| Q2 '24 | 0 | 0 | 0 | -3M | -2.7M | -0.080 |
| Q1 '24 | 0 | 0 | 0 | -3M | -2.6M | -0.084 |
| Q4 '23 | 0 | 0 | 0 | -3.8M | -4.5M | -0.110 |
| Q3 '23 | 0 | 0 | 0 | -6.4M | -6.1M | -0.230 |
Insider Transactions View All
| DeSilva Tara filed to buy 30,466 shares at $0.6. January 16 '24 |
| DeSilva Tara filed to buy 32,266 shares at $0.6. January 16 '24 |
| Cogley Brian filed to buy 30,000 shares at $0.7. January 17 '24 |
| Mehalick David filed to buy 2,768,611 shares at $0.7. January 9 '24 |
| Mehalick David filed to buy 2,782,615 shares at $0.7. January 9 '24 |
Similar companies
Read more about Coeptis Therapeutics (COEP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Coeptis Therapeutics?
The Market Cap of Coeptis Therapeutics is $8.1M.
What is the current stock price of Coeptis Therapeutics?
Currently, the price of one share of Coeptis Therapeutics stock is $0.20.
How can I analyze the COEP stock price chart for investment decisions?
The COEP stock price chart above provides a comprehensive visual representation of Coeptis Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Coeptis Therapeutics shares. Our platform offers an up-to-date COEP stock price chart, along with technical data analysis and alternative data insights.
Does COEP offer dividends to its shareholders?
As of our latest update, Coeptis Therapeutics (COEP) does not offer dividends to its shareholders. Investors interested in Coeptis Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Coeptis Therapeutics?
Some of the similar stocks of Coeptis Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.